Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parkinson's Disease

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 140 articles:
HTML format



Single Articles


    January 2021
  1. BOUSSAC M, Arbus C, Dupouy J, Harroch E, et al
    Personality dimensions of patients can change during the course of parkinson's disease.
    PLoS One. 2021;16:e0245142.
    PubMed     Abstract available


  2. KAMIENIARZ A, Michalska J, Marszalek W, Stania M, et al
    Detection of postural control in early Parkinson's disease: Clinical testing vs. modulation of center of pressure.
    PLoS One. 2021;16:e0245353.
    PubMed     Abstract available


  3. KITANI-MORII F, Kasai T, Horiguchi G, Teramukai S, et al
    Risk factors for neuropsychiatric symptoms in patients with Parkinson's disease during COVID-19 pandemic in Japan.
    PLoS One. 2021;16:e0245864.
    PubMed     Abstract available


  4. SHALASH AS, Hamid E, Elrassas H, Bahbah EI, et al
    Non-motor symptoms in essential tremor, akinetic rigid and tremor-dominant subtypes of Parkinson's disease.
    PLoS One. 2021;16:e0245918.
    PubMed     Abstract available


  5. FORNS J, Layton JB, Bartsch J, Turner ME, et al
    Increased risk of falls and fractures in patients with psychosis and Parkinson disease.
    PLoS One. 2021;16:e0246121.
    PubMed     Abstract available


  6. PARK KH, Sun S, Lim YH, Park HR, et al
    Clinical outcome prediction from analysis of microelectrode recordings using deep learning in subthalamic deep brain stimulation for Parkinson`s disease.
    PLoS One. 2021;16:e0244133.
    PubMed     Abstract available


  7. MAHMOUDZADEH M, Wallois F, Tir M, Krystkowiak P, et al
    Cortical hemodynamic mapping of subthalamic nucleus deep brain stimulation in Parkinsonian patients, using high-density functional near-infrared spectroscopy.
    PLoS One. 2021;16:e0245188.
    PubMed     Abstract available


  8. LIN I, Edison B, Mantri S, Albert S, et al
    Triggers and alleviating factors for fatigue in Parkinson's disease.
    PLoS One. 2021;16:e0245285.
    PubMed     Abstract available


  9. SICA M, Tedesco S, Crowe C, Kenny L, et al
    Continuous home monitoring of Parkinson's disease using inertial sensors: A systematic review.
    PLoS One. 2021;16:e0246528.
    PubMed     Abstract available


  10. OVEISGHARAN S, Yu L, Bennett DA, Buchman AS, et al
    Incident mobility disability, parkinsonism, and mortality in community-dwelling older adults.
    PLoS One. 2021;16:e0246206.
    PubMed     Abstract available


  11. NAGANO T, Kakuma T, Umezu Y, Yanagawa T, et al
    Nutritional status and activities of daily living in patients with Parkinson's disease.
    PLoS One. 2021;16:e0246329.
    PubMed     Abstract available


  12. BURIL J, Burilova P, Pokorna A, Kovacova I, et al
    Representation of Parkinson's disease and atypical Parkinson's syndromes in the Czech Republic-A nationwide retrospective study.
    PLoS One. 2021;16:e0246342.
    PubMed     Abstract available



  13. Retraction: Ectopic Pregnancy-Derived Human Trophoblastic Stem Cells Regenerate Dopaminergic Nigrostriatal Pathway to Treat Parkinsonian Rats.
    PLoS One. 2021;16:e0247151.
    PubMed    


  14. LEE JW, Song YS, Kim H, Ku BD, et al
    Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson's disease: Analysis of the PPMI data.
    PLoS One. 2021;16:e0246881.
    PubMed     Abstract available


  15. IIJIMA M, Okuma Y, Suzuki K, Yoshii F, et al
    Associations between probable REM sleep behavior disorder, olfactory disturbance, and clinical symptoms in Parkinson's disease: A multicenter cross-sectional study.
    PLoS One. 2021;16:e0247443.
    PubMed     Abstract available


  16. VARRECCHIA T, Castiglia SF, Ranavolo A, Conte C, et al
    An artificial neural network approach to detect presence and severity of Parkinson's disease via gait parameters.
    PLoS One. 2021;16:e0244396.
    PubMed     Abstract available


  17. AGURTO C, Heisig S, Abrami A, Ho BK, et al
    Parkinson's disease medication state and severity assessment based on coordination during walking.
    PLoS One. 2021;16:e0244842.
    PubMed     Abstract available


  18. BARGIOTAS I, Kalogeratos A, Limnios M, Vidal PP, et al
    Revealing posturographic profile of patients with Parkinsonian syndromes through a novel hypothesis testing framework based on machine learning.
    PLoS One. 2021;16:e0246790.
    PubMed     Abstract available


  19. DZIECIOL K, Iordanishvili E, Abbas Z, Nahimi A, et al
    A robust method for the detection of small changes in relaxation parameters and free water content in the vicinity of the substantia nigra in Parkinson's disease patients.
    PLoS One. 2021;16:e0247552.
    PubMed     Abstract available


  20. JEONG S, Cho H, Kim YJ, Ma HI, et al
    Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson's disease.
    PLoS One. 2021;16:e0247354.
    PubMed     Abstract available


  21. PHAM U, Skogseid IM, Pripp AH, Boen E, et al
    Impulsivity in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation-An exploratory study.
    PLoS One. 2021;16:e0248568.
    PubMed     Abstract available


  22. MANTRI S, Klawson E, Albert S, Rapoport R, et al
    The experience of care partners of patients with Parkinson's disease psychosis.
    PLoS One. 2021;16:e0248968.
    PubMed     Abstract available


  23. SEBATE B, Cuttler K, Cloete R, Britz M, et al
    Prioritization of candidate genes for a South African family with Parkinson's disease using in-silico tools.
    PLoS One. 2021;16:e0249324.
    PubMed     Abstract available


  24. LOVEGROVE CJ, Bannigan K
    What is the lived experience of anxiety for people with Parkinson's? A phenomenological study.
    PLoS One. 2021;16:e0249390.
    PubMed     Abstract available


  25. SIRAGY T, Hill A, Nantel J
    Recovery of dynamic stability during slips unaffected by arm swing in people with Parkinson's Disease.
    PLoS One. 2021;16:e0249303.
    PubMed     Abstract available



  26. Correction: A genetic analysis of a Spanish population with early onset Parkinson's disease.
    PLoS One. 2021;16:e0249805.
    PubMed     Abstract available


  27. JENSEN BR, Malling ASB, Schmidt SI, Meyer M, et al
    Long-term treatment with transcranial pulsed electromagnetic fields improves movement speed and elevates cerebrospinal erythropoietin in Parkinson's disease.
    PLoS One. 2021;16:e0248800.
    PubMed     Abstract available


  28. SORBERA C, Brigandi A, Cimino V, Bonanno L, et al
    The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study.
    PLoS One. 2021;16:e0251313.
    PubMed     Abstract available


  29. KROTINGER A, Loui P
    Rhythm and groove as cognitive mechanisms of dance intervention in Parkinson's disease.
    PLoS One. 2021;16:e0249933.
    PubMed     Abstract available


  30. LOLEKHA P, Sriphanom T, Vilaichone RK
    Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson's disease patients: A prospective cohort study (HP-PD trial).
    PLoS One. 2021;16:e0251042.
    PubMed     Abstract available


  31. FREIDLE M, Johansson H, Lebedev AV, Ekman U, et al
    Measuring implicit sequence learning and dual task ability in mild to moderate Parkinson s disease: A feasibility study.
    PLoS One. 2021;16:e0251849.
    PubMed     Abstract available


  32. SHRESTHA S, Parks CG, Richards-Barber M, Chen H, et al
    Parkinson's disease case ascertainment in a large prospective cohort.
    PLoS One. 2021;16:e0251852.
    PubMed     Abstract available


  33. MCKAY JL, Lang KC, Bong SM, Hackney ME, et al
    Abnormal center of mass feedback responses during balance: A potential biomarker of falls in Parkinson's disease.
    PLoS One. 2021;16:e0252119.
    PubMed     Abstract available


  34. RODRIGUEZ-SABATE C, Rodriguez M, Morales I
    Studying the functional connectivity of the primary motor cortex with the binarized cross recurrence plot: The influence of Parkinson's disease.
    PLoS One. 2021;16:e0252565.
    PubMed     Abstract available


  35. BHIDAYASIRI R, Boonmongkol T, Thongchuam Y, Phumphid S, et al
    Correction: Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management.
    PLoS One. 2021;16:e0252988.
    PubMed     Abstract available


  36. SHENG MZ, Fang TC, Chen YH, Chang MH, et al
    Is either anosmia or constipation associated with cognitive dysfunction in Parkinson's disease?
    PLoS One. 2021;16:e0252451.
    PubMed     Abstract available


  37. CARTER B, Hayes C, Smith A, Pennington A, et al
    A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease.
    PLoS One. 2021;16:e0251484.
    PubMed     Abstract available


  38. RHEW SH, Kravchenko J, Lyerly HK
    Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer's disease, non-Alzheimer's dementia, and Parkinson's disease in North Carolina.
    PLoS One. 2021;16:e0253253.
    PubMed     Abstract available


  39. PEARCE P, Bulluss K, Xu SS, Kim B, et al
    How accurately are subthalamic nucleus electrodes implanted relative to the ideal stimulation location for Parkinson's disease?
    PLoS One. 2021;16:e0254504.
    PubMed     Abstract available


  40. KOYANAGI Y, Fukushi I, Nakamura M, Suzuki K, et al
    The effect of body weight-supported overground gait training for patients with Parkinson's disease: A retrospective case-control observational study.
    PLoS One. 2021;16:e0254415.
    PubMed     Abstract available


  41. TAGUCHI S, Koide H, Oiwa H, Hayashi M, et al
    Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease.
    PLoS One. 2021;16:e0255274.
    PubMed     Abstract available


  42. VACCARI C, Grotto D, Pereira TDV, de Camargo JLV, et al
    GLP-1 and GIP receptor agonists in the treatment of Parkinson's disease: Translational systematic review and meta-analysis protocol of clinical and preclinical studies.
    PLoS One. 2021;16:e0255726.
    PubMed     Abstract available


  43. WARDEN MN, Searles Nielsen S, Camacho-Soto A, Garnett R, et al
    A comparison of prediction approaches for identifying prodromal Parkinson disease.
    PLoS One. 2021;16:e0256592.
    PubMed     Abstract available


  44. ARISTOTELIDOU V, Tsatali M, Overton PG, Vivas AB, et al
    Autonomic factors do not underlie the elevated self-disgust levels in Parkinson's disease.
    PLoS One. 2021;16:e0256144.
    PubMed     Abstract available


  45. BRAKEDAL B, Tzoulis C, Tysnes OB, Haugarvoll K, et al
    NSAID use is not associated with Parkinson's disease incidence: A Norwegian Prescription Database study.
    PLoS One. 2021;16:e0256602.
    PubMed     Abstract available


  46. BARTL M, Dakna M, Galasko D, Hutten SJ, et al
    Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
    PLoS One. 2021;16:e0257372.
    PubMed     Abstract available


  47. PARDOEL S, Shalin G, Lemaire ED, Kofman J, et al
    Grouping successive freezing of gait episodes has neutral to detrimental effect on freeze detection and prediction in Parkinson's disease.
    PLoS One. 2021;16:e0258544.
    PubMed     Abstract available


  48. AOUN K, Double KL, Pearson-Dennett V, Yilmaz R, et al
    Measurement of the adult human midbrain with transcranial ultrasound.
    PLoS One. 2021;16:e0247920.
    PubMed     Abstract available


  49. MA A, Lau KK, Thyagarajan D
    Radiological correlates of vocal fold bowing as markers of Parkinson's disease progression: A cross-sectional study utilizing dynamic laryngeal CT.
    PLoS One. 2021;16:e0258786.
    PubMed     Abstract available


  50. AHN JH, Seok JM, Park J, Jeong H, et al
    Validation of the Korean version of the composite autonomic symptom scale 31 in patients with Parkinson's disease.
    PLoS One. 2021;16:e0258897.
    PubMed     Abstract available


  51. PRELL T, Liebermann JD, Mendorf S, Lehmann T, et al
    Pain coping strategies and their association with quality of life in people with Parkinson's disease: A cross-sectional study.
    PLoS One. 2021;16:e0257966.
    PubMed     Abstract available


  52. BAILEY DK, Clark W, Kosman DJ
    The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells.
    PLoS One. 2021;16:e0254794.
    PubMed     Abstract available


  53. NEJTEK VA, James RN, Salvatore MF, Alphonso HM, et al
    Premature cognitive decline in specific domains found in young veterans with mTBI coincide with elder normative scores and advanced-age subjects with early-stage Parkinson's disease.
    PLoS One. 2021;16:e0258851.
    PubMed     Abstract available


  54. SHAMADYKOVA DV, Panteleev DY, Kust NN, Savchenko EA, et al
    Neuroinductive properties of mGDNF depend on the producer, E. Coli or human cells.
    PLoS One. 2021;16:e0258289.
    PubMed     Abstract available


  55. ELFARRASH S, Jensen NM, Ferreira N, Schmidt SI, et al
    Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein.
    PLoS One. 2021;16:e0252635.
    PubMed     Abstract available


    January 2020
  56. JEON N, Bortolato M
    What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study.
    PLoS One. 2020;15:e0227128.
    PubMed     Abstract available


  57. YAFFE JA, Zlotnik Y, Ifergane G, Levy-Tzedek S, et al
    Implicit task switching in Parkinson's disease is preserved when on medication.
    PLoS One. 2020;15:e0227555.
    PubMed     Abstract available


  58. KAWASAKI T, Mikami K, Kamo T, Aoki R, et al
    Correction: Motor planning error in Parkinson's disease and its clinical correlates.
    PLoS One. 2020;15:e0228698.
    PubMed     Abstract available


  59. SHIIBA T, Arimura Y, Nagano M, Takahashi T, et al
    Improvement of classification performance of Parkinson's disease using shape features for machine learning on dopamine transporter single photon emission computed tomography.
    PLoS One. 2020;15:e0228289.
    PubMed     Abstract available


  60. GERA A, O'Keefe JA, Ouyang B, Liu Y, et al
    Gait asymmetry in glucocerebrosidase mutation carriers with Parkinson's disease.
    PLoS One. 2020;15:e0226494.
    PubMed     Abstract available



  61. Retraction: DJ-1 Modulates alpha-Synuclein Aggregation State in a Cellular Model of Oxidative Stress: Relevance for Parkinson's Disease and Involvement of HSP70.
    PLoS One. 2020;15:e0219023.
    PubMed    


  62. JEONG YJ, Jeong JE, Cheon SM, Yoon BA, et al
    Relationship between the washout rate of I-123 MIBG scans and autonomic function in Parkinson's disease.
    PLoS One. 2020;15:e0229860.
    PubMed     Abstract available


  63. URSINO M, Magosso E, Lopane G, Calandra-Buonaura G, et al
    Mathematical modeling and parameter estimation of levodopa motor response in patients with parkinson disease.
    PLoS One. 2020;15:e0229729.
    PubMed     Abstract available


  64. LIMA DP, de Almeida SB, Bonfadini JC, de Luna JRG, et al
    Clinical correlates of sarcopenia and falls in Parkinson's disease.
    PLoS One. 2020;15:e0227238.
    PubMed     Abstract available


  65. LEE J, Lee AL, Park JH, Moon JE, et al
    The clinical application of nigrosome 1 detection on high-resolution susceptibility-weighted imaging in the evaluation of suspected Parkinsonism: The real-world performance and pitfalls.
    PLoS One. 2020;15:e0231010.
    PubMed     Abstract available



  66. Expression of Concern: Mucuna pruriens (Velvet bean) Rescues Motor, Olfactory, Mitochondrial and Synaptic Impairment in PINK1B9 Drosophila melanogaster Genetic Model of Parkinson's Disease.
    PLoS One. 2020;15:e0231371.
    PubMed    


  67. BECK EN, Wang MTY, Intzandt BN, Almeida QJ, et al
    Sensory focused exercise improves anxiety in Parkinson's disease: A randomized controlled trial.
    PLoS One. 2020;15:e0230803.
    PubMed     Abstract available


  68. EMELYANOV A, Shtam T, Kamyshinsky R, Garaeva L, et al
    Cryo-electron microscopy of extracellular vesicles from cerebrospinal fluid.
    PLoS One. 2020;15:e0227949.
    PubMed     Abstract available


  69. SUZUKI M, Arai M, Hayashi A, Ogino M, et al
    Adherence to treatment guideline recommendations for Parkinson's disease in Japan: A longitudinal analysis of a nationwide medical claims database between 2008 and 2016.
    PLoS One. 2020;15:e0230213.
    PubMed     Abstract available


  70. LENNAERTS-KATS H, van der Steen JT, Vijftigschild Z, Steppe M, et al
    RADPAC-PD: A tool to support healthcare professionals in timely identifying palliative care needs of people with Parkinson's disease.
    PLoS One. 2020;15:e0230611.
    PubMed     Abstract available


  71. MULCAHY G, Atwood B, Kuznetsov A
    Basal ganglia role in learning rewarded actions and executing previously learned choices: Healthy and diseased states.
    PLoS One. 2020;15:e0228081.
    PubMed     Abstract available


  72. METZGER JM, Matsoff HN, Zinnen AD, Fleddermann RA, et al
    Post mortem evaluation of inflammation, oxidative stress, and PPARgamma activation in a nonhuman primate model of cardiac sympathetic neurodegeneration.
    PLoS One. 2020;15:e0226999.
    PubMed     Abstract available


  73. OVEISGHARAN S, Dawe RJ, Leurgans SE, Yu L, et al
    Total daily physical activity, brain pathologies, and parkinsonism in older adults.
    PLoS One. 2020;15:e0232404.
    PubMed     Abstract available


  74. WU W, Sung CC, Yu P, Li J, et al
    S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease.
    PLoS One. 2020;15:e0232019.
    PubMed     Abstract available


  75. GIANNAKAKIS E, Hutchings F, Papasavvas CA, Han CE, et al
    Computational modelling of the long-term effects of brain stimulation on the local and global structural connectivity of epileptic patients.
    PLoS One. 2020;15:e0221380.
    PubMed     Abstract available


  76. SANCHEZ-LANZAS R, Castano JG
    Correction: Inhibitors of lysosomal function or serum starvation in control or LAMP2 deficient cells do not modify the cellular levels of Parkinson disease-associated DJ-1/PARK 7 protein.
    PLoS One. 2020;15:e0233091.
    PubMed     Abstract available


  77. GRUBER MT, Witte OW, Grosskreutz J, Prell T, et al
    Association between malnutrition, clinical parameters and health-related quality of life in elderly hospitalized patients with Parkinson's disease: A cross-sectional study.
    PLoS One. 2020;15:e0232764.
    PubMed     Abstract available


  78. KRISHNAGOPAL S, Coelln RV, Shulman LM, Girvan M, et al
    Identifying and predicting Parkinson's disease subtypes through trajectory clustering via bipartite networks.
    PLoS One. 2020;15:e0233296.
    PubMed     Abstract available


  79. WU W, Sung CC, Yu P, Li J, et al
    Correction: S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease.
    PLoS One. 2020;15:e0235296.
    PubMed     Abstract available


  80. KUMSA A, Agenagnew L, Alemu B, Girma S, et al
    Psychotropic medications induced parkinsonism and akathisia in people attending follow-up treatment at Jimma Medical Center, Psychiatry Clinic.
    PLoS One. 2020;15:e0235365.
    PubMed     Abstract available


  81. REEDIJK M, Huss A, Verheij RA, Peeters PH, et al
    Parkinson's disease case ascertainment in prospective cohort studies through combining multiple health information resources.
    PLoS One. 2020;15:e0234845.
    PubMed     Abstract available


  82. JUUTINEN M, Wang C, Zhu J, Haladjian J, et al
    Parkinson's disease detection from 20-step walking tests using inertial sensors of a smartphone: Machine learning approach based on an observational case-control study.
    PLoS One. 2020;15:e0236258.
    PubMed     Abstract available


  83. TERRENS AF, Soh SE, Morgan P
    The safety and feasibility of a Halliwick style of aquatic physiotherapy for falls and balance dysfunction in people with Parkinson's Disease: A single blind pilot trial.
    PLoS One. 2020;15:e0236391.
    PubMed     Abstract available


  84. CHANG YP, Lee MS, Wu DW, Tsai JH, et al
    Risk factors for depression in patients with Parkinson's disease: A nationwide nested case-control study.
    PLoS One. 2020;15:e0236443.
    PubMed     Abstract available


  85. O'DAY J, Syrkin-Nikolau J, Anidi C, Kidzinski L, et al
    The turning and barrier course reveals gait parameters for detecting freezing of gait and measuring the efficacy of deep brain stimulation.
    PLoS One. 2020;15:e0231984.
    PubMed     Abstract available


  86. CARAPELLOTTI AM, Stevenson R, Doumas M
    The efficacy of dance for improving motor impairments, non-motor symptoms, and quality of life in Parkinson's disease: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0236820.
    PubMed     Abstract available


  87. SZATMARI S JR, Ajtay A, Oberfrank F, Dobi B, et al
    The prevalence of psychiatric symptoms before the diagnosis of Parkinson's disease in a nationwide cohort: A comparison to patients with cerebral infarction.
    PLoS One. 2020;15:e0236728.
    PubMed     Abstract available


  88. MICHALSKA J, Kamieniarz A, Brachman A, Marszalek W, et al
    Fall-related measures in elderly individuals and Parkinson's disease subjects.
    PLoS One. 2020;15:e0236886.
    PubMed     Abstract available


  89. HONG JY, Sunwoo MK, Yoon JH, Kang SY, et al
    Rapid drug increase and early onset of levodopa-induced dyskinesia in Parkinson's disease.
    PLoS One. 2020;15:e0237472.
    PubMed     Abstract available


  90. DONG M, Li L, Chen M, Kusalik A, et al
    Predictive analysis methods for human microbiome data with application to Parkinson's disease.
    PLoS One. 2020;15:e0237779.
    PubMed     Abstract available


  91. MARTINEZ-MARTIN P, Deuschl G, Tonder L, Schnitzler A, et al
    Interpretation of health-related quality of life outcomes in Parkinson's disease from the EARLYSTIM Study.
    PLoS One. 2020;15:e0237498.
    PubMed     Abstract available


  92. LIU HC, Lin WC, Chiu MJ, Lu CH, et al
    Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology.
    PLoS One. 2020;15:e0234519.
    PubMed     Abstract available


  93. CRISTINA TP, Pablo M, Teresa PM, Lydia VD, et al
    A genetic analysis of a Spanish population with early onset Parkinson's disease.
    PLoS One. 2020;15:e0238098.
    PubMed     Abstract available


  94. FLEISHER JE, Sennott BJ, Myrick E, Niemet CJ, et al
    KICK OUT PD: Feasibility and quality of life in the pilot karate intervention to change kinematic outcomes in Parkinson's Disease.
    PLoS One. 2020;15:e0237777.
    PubMed     Abstract available


  95. GASPAR R, Garting T, Stradner A
    Eye lens crystallin proteins inhibit the autocatalytic amyloid amplification nature of mature alpha-synuclein fibrils.
    PLoS One. 2020;15:e0235198.
    PubMed     Abstract available


  96. NAGANUMA R, Yabe I, Takeuchi M, Morishita K, et al
    Clinical factors affecting evoked magnetic fields in patients with Parkinson's disease.
    PLoS One. 2020;15:e0232808.
    PubMed     Abstract available


  97. LI H, Liang S, Yu Y, Wang Y, et al
    Effect of Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) on balance performance in Parkinson's disease.
    PLoS One. 2020;15:e0238936.
    PubMed     Abstract available


  98. GAARE JJ, Nido G, Dolle C, Sztromwasser P, et al
    Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci.
    PLoS One. 2020;15:e0239824.
    PubMed     Abstract available


  99. SATO K, Mano T, Iwata A, Toda T, et al
    Autocorrelation-based method to identify disordered rhythm in Parkinson's disease tasks: A novel approach applicable to multimodal devices.
    PLoS One. 2020;15:e0238486.
    PubMed     Abstract available


  100. MONSELLIER E, Bendifallah M, Redeker V, Melki R, et al
    Polypeptides derived from alpha-Synuclein binding partners to prevent alpha-Synuclein fibrils interaction with and take-up by cells.
    PLoS One. 2020;15:e0237328.
    PubMed     Abstract available


  101. GLASS TJ, Kelm-Nelson CA, Szot JC, Lake JM, et al
    Functional characterization of extrinsic tongue muscles in the Pink1-/- rat model of Parkinson disease.
    PLoS One. 2020;15:e0240366.
    PubMed     Abstract available


  102. TANAKA R, Yamashiro K, Ogawa T, Oyama G, et al
    The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson's disease.
    PLoS One. 2020;15:e0240491.
    PubMed     Abstract available


  103. KUBOTA M, Kobayashi N, Sugizaki T, Shimoda M, et al
    Carnosine suppresses neuronal cell death and inflammation induced by 6-hydroxydopamine in an in vitro model of Parkinson's disease.
    PLoS One. 2020;15:e0240448.
    PubMed     Abstract available


  104. MORI Y, Yoshikawa E, Futatsubashi M, Ouchi Y, et al
    Neural correlates of standing imagery and execution in Parkinsonian patients: The relevance to striatal dopamine dysfunction.
    PLoS One. 2020;15:e0240998.
    PubMed     Abstract available



  105. Retraction: Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and Neurturin In Vitro: Potential therapeutic application for Parkinson's disease in a rhesus monkey model.
    PLoS One. 2020;15:e0242032.
    PubMed    


  106. JENG B, Cederberg KLJ, Lai B, Sasaki JE, et al
    Accelerometer output and its association with energy expenditure in persons with mild-to-moderate Parkinson's disease.
    PLoS One. 2020;15:e0242136.
    PubMed     Abstract available


  107. FAZELI S, Motovali-Bashi M, Peymani M, Hashemi MS, et al
    A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease.
    PLoS One. 2020;15:e0240855.
    PubMed     Abstract available


  108. MALINOVA V, Pinter A, Dragaescu C, Rohde V, et al
    The role of intraoperative microelectrode recording and stimulation in subthalamic lead placement for Parkinson's disease.
    PLoS One. 2020;15:e0241752.
    PubMed     Abstract available


  109. MURUGAPPAN M, Alshuaib W, Bourisly AK, Khare SK, et al
    Tunable Q wavelet transform based emotion classification in Parkinson's disease using Electroencephalography.
    PLoS One. 2020;15:e0242014.
    PubMed     Abstract available


  110. BHIDAYASIRI R, Boonmongkol T, Thongchuam Y, Phumphid S, et al
    Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management.
    PLoS One. 2020;15:e0243051.
    PubMed     Abstract available


  111. PINTO C, Salazar AP, Hennig EM, Kerr G, et al
    Dual-task walking reduces lower limb range of motion in individuals with Parkinson's disease and freezing of gait: But does it happen during what events through the gait cycle?
    PLoS One. 2020;15:e0243133.
    PubMed     Abstract available


  112. BAUMANN-VOGEL H, Hor H, Poryazova R, Valko P, et al
    REM sleep behavior in Parkinson disease: Frequent, particularly with higher age.
    PLoS One. 2020;15:e0243454.
    PubMed     Abstract available


  113. ANDERSSON N, Nilsson MH, Slaug B, Oswald F, et al
    The meaning of home questionnaire revisited: Psychometric analyses among people with Parkinson's disease reveals new dimensions.
    PLoS One. 2020;15:e0242792.
    PubMed     Abstract available


  114. TORTI M, Fossati C, Casali M, De Pandis MF, et al
    Effect of family history, occupation and diet on the risk of Parkinson disease: A case-control study.
    PLoS One. 2020;15:e0243612.
    PubMed     Abstract available


  115. PETROZZIELLO T, Dios AM, Mueller KA, Vaine CA, et al
    SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene.
    PLoS One. 2020;15:e0243655.
    PubMed     Abstract available


  116. POLAKOVA K, Ruzicka E, Jech R, Kemlink D, et al
    3D visual cueing shortens the double support phase of the gait cycle in patients with advanced Parkinson's disease treated with DBS of the STN.
    PLoS One. 2020;15:e0244676.
    PubMed     Abstract available


  117. IBRAHIM A, Ali RAR, Manaf MRA, Ahmad N, et al
    Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson's disease: A randomised controlled trial.
    PLoS One. 2020;15:e0244680.
    PubMed     Abstract available


  118. SHIM M, Bang WJ, Oh CY, Lee YS, et al
    Risk of dementia and Parkinson's disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0244660.
    PubMed     Abstract available


  119. FAZELI S, Motovali-Bashi M, Peymani M, Hashemi MS, et al
    Correction: A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease.
    PLoS One. 2020;15:e0244776.
    PubMed     Abstract available


  120. EHLEN F, Al-Fatly B, Kuhn AA, Klostermann F, et al
    Impact of deep brain stimulation of the subthalamic nucleus on natural language in patients with Parkinson's disease.
    PLoS One. 2020;15:e0244148.
    PubMed     Abstract available


  121. PRAVEEN RAJNEESH C, Liou JC, Hsieh TH, Lin JH, et al
    The voiding efficiency in rat models with dopaminergic brain lesions induced through unilateral and bilateral intrastriatal injections.
    PLoS One. 2020;15:e0243452.
    PubMed     Abstract available


    January 2019
  122. STEGEMOLLER EL, Zaman A, Uzochukwu J
    Repetitive finger movement and circle drawing in persons with Parkinson's disease.
    PLoS One. 2019;14:e0222862.
    PubMed     Abstract available


  123. BORDONI L, Gabbianelli R, Fedeli D, Fiorini D, et al
    Positive effect of an electrolyzed reduced water on gut permeability, fecal microbiota and liver in an animal model of Parkinson's disease.
    PLoS One. 2019;14:e0223238.
    PubMed     Abstract available


  124. TSATALI M, Overton PG, Vivas AB
    Self-reported and experimentally induced self-disgust is heightened in Parkinson's disease: Contribution of behavioural symptoms.
    PLoS One. 2019;14:e0223663.
    PubMed     Abstract available


  125. ZHU Y, Pu J, Chen Y, Zhang B, et al
    Decreased risk of Parkinson's disease in diabetic patients with thiazolidinediones therapy: An exploratory meta-analysis.
    PLoS One. 2019;14:e0224236.
    PubMed     Abstract available


  126. LEI C, Sunzi K, Dai F, Liu X, et al
    Effects of virtual reality rehabilitation training on gait and balance in patients with Parkinson's disease: A systematic review.
    PLoS One. 2019;14:e0224819.
    PubMed     Abstract available


  127. SATO K, Nagashima Y, Mano T, Iwata A, et al
    Quantifying normal and parkinsonian gait features from home movies: Practical application of a deep learning-based 2D pose estimator.
    PLoS One. 2019;14:e0223549.
    PubMed     Abstract available


  128. PINKHARDT EH, Liu H, Ma D, Chen J, et al
    Olfactory screening of Parkinson's Disease patients and healthy subjects in China and Germany: A study of cross-cultural adaptation of the Sniffin' Sticks 12-identification test.
    PLoS One. 2019;14:e0224331.
    PubMed     Abstract available


  129. KALILANI L, Friesen D, Boudiaf N, Asgharnejad M, et al
    The characteristics and treatment patterns of patients with Parkinson's disease in the United States and United Kingdom: A retrospective cohort study.
    PLoS One. 2019;14:e0225723.
    PubMed     Abstract available


  130. MAEGAWA H, Adachi N, Hanamoto H, Kudo C, et al
    Bilateral Parkinson's disease model rats exhibit hyperalgesia to subcutaneous formalin administration into the vibrissa pad.
    PLoS One. 2019;14:e0225928.
    PubMed     Abstract available


  131. CHEN F, Wu T, Luo Y, Li Z, et al
    Amnestic mild cognitive impairment in Parkinson's disease: White matter structural changes and mechanisms.
    PLoS One. 2019;14:e0226175.
    PubMed     Abstract available


  132. MARTINEZ A, Ibarra IA, Vargas R
    A quantum chemical approach representing a new perspective concerning agonist and antagonist drugs in the context of schizophrenia and Parkinson's disease.
    PLoS One. 2019;14:e0224691.
    PubMed     Abstract available


  133. READ J, Cable S, Lofqvist C, Iwarsson S, et al
    Experiences of health services and unmet care needs of people with late-stage Parkinson's in England: A qualitative study.
    PLoS One. 2019;14:e0226916.
    PubMed     Abstract available


  134. VAN DIGGELEN F, Hrle D, Apetri M, Christiansen G, et al
    Two conformationally distinct alpha-synuclein oligomers share common epitopes and the ability to impair long-term potentiation.
    PLoS One. 2019;14:e0213663.
    PubMed     Abstract available


  135. NGUYEN TAK, Djilas M, Nowacki A, Mercanzini A, et al
    Analysis of patient-specific stimulation with segmented leads in the subthalamic nucleus.
    PLoS One. 2019;14:e0217985.
    PubMed     Abstract available


  136. CALLIZOT N, Combes M, Henriques A, Poindron P, et al
    Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins.
    PLoS One. 2019;14:e0215277.
    PubMed     Abstract available


  137. OSUAGWU N, Dolle C, Tzoulis C
    Poly-ADP-ribose assisted protein localization resolves that DJ-1, but not LRRK2 or alpha-synuclein, is localized to the mitochondrial matrix.
    PLoS One. 2019;14:e0219909.
    PubMed     Abstract available


  138. RUESINK H, Reimer L, Gregersen E, Moeller A, et al
    Stabilization of alpha-synuclein oligomers using formaldehyde.
    PLoS One. 2019;14:e0216764.
    PubMed     Abstract available


  139. TSANG AR, Rajakumar N, Jog MS
    Botulinum toxin A injection into the entopeduncular nucleus improves dynamic locomotory parameters in hemiparkinsonian rats.
    PLoS One. 2019;14:e0223450.
    PubMed     Abstract available


  140. UGOLINO J, Dziki KM, Kim A, Wu JJ, et al
    Overexpression of human Atp13a2Isoform-1 protein protects cells against manganese and starvation-induced toxicity.
    PLoS One. 2019;14:e0220849.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: